Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

750 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine.
Nantel S, Bourdin B, Adams K, Carbonneau J, Rabezanahary H, Hamelin MÈ, McCormack D, Savard P, Longtin Y, Cheng MP, De Serres G, Corbeil J, Gilca V, Baz M, Boivin G, Quach C, Decaluwe H. Nantel S, et al. Among authors: boivin g. Front Immunol. 2022 Oct 14;13:930252. doi: 10.3389/fimmu.2022.930252. eCollection 2022. Front Immunol. 2022. PMID: 36311736 Free PMC article.
Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice.
Ogonczyk-Makowska D, Brun P, Vacher C, Chupin C, Droillard C, Carbonneau J, Laurent E, Dulière V, Traversier A, Terrier O, Julien T, Galloux M, Paul S, Eléouët JF, Fouret J, Hamelin ME, Pizzorno A, Boivin G, Rosa-Calatrava M, Dubois J. Ogonczyk-Makowska D, et al. Among authors: boivin g. NPJ Vaccines. 2024 Jun 19;9(1):111. doi: 10.1038/s41541-024-00899-9. NPJ Vaccines. 2024. PMID: 38898106 Free PMC article.
Omicron incidence and seroprevalence among children in Montreal, Canada, in early 2023: final results from the longitudinal EnCORE serology study.
Charland K, Pierce L, Saucier A, Hamelin MÈ, Barbosa Da Torre M, Carbonneau J, Nguyen CT, De Serres G, Papenburg J, Boivin G, Quach C, Zinszer K. Charland K, et al. Among authors: boivin g. Epidemiol Infect. 2024 Sep 25;152:e103. doi: 10.1017/S0950268824000797. Epidemiol Infect. 2024. PMID: 39320472 Free PMC article.
Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montréal, Canada.
Zinszer K, Charland K, Pierce L, Saucier A, McKinnon B, Hamelin MÈ, Cheriet I, Da Torre MB, Carbonneau J, Nguyen CT, De Serres G, Papenburg J, Boivin G, Quach C. Zinszer K, et al. Among authors: boivin g. Int J Infect Dis. 2023 Jun;131:119-126. doi: 10.1016/j.ijid.2023.03.036. Epub 2023 Mar 23. Int J Infect Dis. 2023. PMID: 36963656 Free PMC article.
Author Correction: Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice.
Ogonczyk-Makowska D, Brun P, Vacher C, Chupin C, Droillard C, Carbonneau J, Laurent E, Dulière V, Traversier A, Terrier O, Julien T, Galloux M, Paul S, Eléouët JF, Fouret J, Hamelin ME, Pizzorno A, Boivin G, Rosa-Calatrava M, Dubois J. Ogonczyk-Makowska D, et al. Among authors: boivin g. NPJ Vaccines. 2024 Jul 9;9(1):125. doi: 10.1038/s41541-024-00917-w. NPJ Vaccines. 2024. PMID: 38982077 Free PMC article. No abstract available.
Parental decisions regarding the vaccination of children and adolescents against SARS-CoV-2 from 2020 to 2023: A descriptive longitudinal study of parents and children in Montreal, Canada.
Charland K, Quach C, Papenburg J, Pierce L, Tuong Nguyen C, Saucier A, Barbosa Da Torre M, Hamelin MÈ, Carbonneau J, Boivin G, Zinszer K. Charland K, et al. Among authors: boivin g. Vaccine. 2024 Nov 2;43(Pt 1):126489. doi: 10.1016/j.vaccine.2024.126489. Online ahead of print. Vaccine. 2024. PMID: 39489137 Free article.
Evaluation of the performance of multiple immunoassay diagnostic platforms on the National Microbiology Laboratory SARS-CoV-2 National Serology Panel.
Dibernardo A, Toledo NP, Robinson A, Osiowy C, Giles E, Day J, Robbin Lindsay L, Drebot MA, Booth TF, Pidduck T, Baily A, Charlton CL, Tipples G, Kanji JN, Brochu G, Lang A, Therrien C, Bélanger-Collard M, Beaulac SN, Gilfix BM, Boivin G, Hamelin MÈ, Carbonneau J, Lévesque S, Martin P, Finzi A, Gendron-Lepage G, Goyette G, Benlarbi M, Gasser R, Fortin C, Martel-Lafferrière V, Lavoie M, Guérin R, Haraoui LP, Renaud C, Jenkins C, O'Brien SF, Drews SJ, Conrod V, Tran V, Awrey B, Scheuermann R, DuPuis A, Payne A, Warszycki C, Girardin R, Lee W, Zahariadis G, Jiao L, Needle R, Cordenbach J, Zaharatos J, Taylor K, Teltscher M, Miller M, Elsherif M, Robertson P, Robinson JL. Dibernardo A, et al. Among authors: boivin g. J Assoc Med Microbiol Infect Dis Can. 2022 Sep 27;7(3):186-195. doi: 10.3138/jammi-2021-0026. eCollection 2022 Sep. J Assoc Med Microbiol Infect Dis Can. 2022. PMID: 36337598 Free PMC article.
750 results